Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Epidemiologic and clinical implications of second-generation pneumococcal conjugate vaccines.

Literature DB >> 23381547

Epidemiologic and clinical implications of second-generation pneumococcal conjugate vaccines.

Carmen Muñoz-Almagro¹, Adoracion Navarro-Torne, Roman Pallares.

Abstract

This review is based on published literature about some of the potential advantages and challenges of the second generation of pneumococcal conjugate vaccines, with special reference to 13-valent vaccine in children and adults.

Entities: Disease Species

Year: 2013 PMID： 23381547 DOI： 10.1007/s11908-013-0326-4

Source DB: PubMed Journal: Curr Infect Dis Rep ISSN： 1523-3847 Impact factor: 3.725

62 in total

1. Impact of pneumococcal vaccination in Denmark during the first 3 years after PCV introduction in the childhood immunization programme.

Authors: Helene Ingels; Jeppe Rasmussen; Peter Henrik Andersen; Zitta B Harboe; Steffen Glismann; Helle Konradsen; Steen Hoffmann; Palle Valentiner-Branth; Lotte Lambertsen
Journal: Vaccine Date: 2012-04-11 Impact factor: 3.641

2. Prevention of antibiotic-nonsusceptible Streptococcus pneumoniae with conjugate vaccines.

Authors: Lee M Hampton; Monica M Farley; William Schaffner; Ann Thomas; Arthur Reingold; Lee H Harrison; Ruth Lynfield; Nancy M Bennett; Susan Petit; Kenneth Gershman; Joan Baumbach; Bernard Beall; James Jorgensen; Anita Glennen; Elizabeth R Zell; Matthew Moore
Journal: J Infect Dis Date: 2011-12-07 Impact factor: 5.226

Review 3. Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project.

Authors: Hope L Johnson; Maria Deloria-Knoll; Orin S Levine; Sonia K Stoszek; Laura Freimanis Hance; Richard Reithinger; Larry R Muenz; Katherine L O'Brien
Journal: PLoS Med Date: 2010-10-05 Impact factor: 11.069

4. Pneumococcal 13-valent conjugate vaccine for the prevention of invasive pneumococcal disease in children and adults.

Authors: Rebecca A Gladstone; Johanna M Jefferies; Saul N Faust; Stuart C Clarke
Journal: Expert Rev Vaccines Date: 2012-08 Impact factor: 5.217

5. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia.

Authors: Steven B Black; Henry R Shinefield; Stella Ling; John Hansen; Bruce Fireman; David Spring; Jack Noyes; Edwin Lewis; Paula Ray; Janelle Lee; Jill Hackell
Journal: Pediatr Infect Dis J Date: 2002-09 Impact factor: 2.129

6. Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children.

Authors: Michael E Pichichero; Janet R Casey
Journal: JAMA Date: 2007-10-17 Impact factor: 56.272

7. Nasal carriage of Streptococcus pneumoniae serotypes and Staphylococcus aureus in Streptococcus pneumoniae-vaccinated and non-vaccinated young children.

Authors: N H T M Dukers-Muijrers; E Stobberingh; P Beisser; R C H Boesten; P Jacobs; C J P A Hoebe
Journal: Epidemiol Infect Date: 2012-06-12 Impact factor: 4.434

Review 8. Impact of pneumococcal conjugate vaccination on otitis media: a systematic review.

Authors: Sylvia Taylor; Paola Marchisio; Anne Vergison; Julie Harriague; William P Hausdorff; Mark Haggard
Journal: Clin Infect Dis Date: 2012-03-15 Impact factor: 9.079

9. Pediatric parapneumonic empyema, Spain.

Authors: Ignacio Obando; Carmen Muñoz-Almagro; Luis A Arroyo; David Tarrago; David Sanchez-Tatay; David Moreno-Perez; Sahar S Dhillon; Cristina Esteva; Susanna Hernandez-Bou; Juan J Garcia-Garcia; William P Hausdorff; Angela B Brueggemann
Journal: Emerg Infect Dis Date: 2008-09 Impact factor: 6.883

10. The burden of community-acquired pneumonia in seniors: results of a population-based study.

Authors: Michael L Jackson; Kathleen M Neuzil; William W Thompson; David K Shay; Onchee Yu; Christi A Hanson; Lisa A Jackson
Journal: Clin Infect Dis Date: 2004-11-08 Impact factor: 9.079

3 in total

Review 1. Dissecting the indirect effects caused by vaccines into the basic elements.

Authors: Carla D Scarbrough Lefebvre; Augustin Terlinden; Baudouin Standaert
Journal: Hum Vaccin Immunother Date: 2015-07-17 Impact factor: 3.452

2. Cost-effectiveness of childhood pneumococcal vaccination program in Ethiopia: results from a quasi-experimental evaluation.

Authors: Tayue Tateke Kebede; Mikael Svensson; Adamu Addissie; Birger Trollfors; Rune Andersson
Journal: BMC Public Health Date: 2019-08-09 Impact factor: 3.295

3. Immunogenicity and Safety of the 13-Valent Pneumococcal Conjugate Vaccine versus the 23-Valent Polysaccharide Vaccine in Unvaccinated HIV-Infected Adults: A Pilot, Prospective Controlled Study.

Authors: Francesca Lombardi; Simone Belmonti; Massimiliano Fabbiani; Matteo Morandi; Barbara Rossetti; Giacinta Tordini; Roberto Cauda; Andrea De Luca; Simona Di Giambenedetto; Francesca Montagnani
Journal: PLoS One Date: 2016-06-03 Impact factor: 3.240

3 in total